Xiying Yu

683 total citations
27 papers, 509 citations indexed

About

Xiying Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiying Yu has authored 27 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Xiying Yu's work include Cancer-related gene regulation (10 papers), Cancer Cells and Metastasis (7 papers) and Epigenetics and DNA Methylation (6 papers). Xiying Yu is often cited by papers focused on Cancer-related gene regulation (10 papers), Cancer Cells and Metastasis (7 papers) and Epigenetics and DNA Methylation (6 papers). Xiying Yu collaborates with scholars based in China, United States and India. Xiying Yu's co-authors include Shih‐Hsin Lu, Liping Guo, Wei Jiang, Xingran Jiang, Linwei Li, Chunpeng Zhang, Yang Yang, Hongxia Li, Shih Hsin Lu and Changjun Zhu and has published in prestigious journals such as Cancer Research, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Xiying Yu

26 papers receiving 504 citations

Peers

Xiying Yu
Mar Haz‐Conde Spain
Young‐Kyoung Shin South Korea
Raquel Batlle Spain
Jae Hwi Song South Korea
Naoki Hayashi Japan
Francisco Hermida‐Prado Spain
Katelyn N. Nelson United States
Chuang Lin China
Yi‐Fang Yang Taiwan
Mar Haz‐Conde Spain
Xiying Yu
Citations per year, relative to Xiying Yu Xiying Yu (= 1×) peers Mar Haz‐Conde

Countries citing papers authored by Xiying Yu

Since Specialization
Citations

This map shows the geographic impact of Xiying Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiying Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiying Yu more than expected).

Fields of papers citing papers by Xiying Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiying Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiying Yu. The network helps show where Xiying Yu may publish in the future.

Co-authorship network of co-authors of Xiying Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiying Yu. A scholar is included among the top collaborators of Xiying Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiying Yu. Xiying Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yuanyuan, Guodong Deng, Xiaohong Yu, et al.. (2025). Unraveling the Oncogenic Characteristics of the Cytolinker, Plectin, in Esophageal Squamous Cell Carcinoma. Cellular and Molecular Gastroenterology and Hepatology. 19(9). 101549–101549.
2.
Zheng, Wei, Hui Yuan, Guodong Deng, et al.. (2024). An effective two-stage NMBzA-induced rat esophageal tumor model revealing that the FAT-Hippo-YAP1 axis drives the progression of ESCC. Cancer Letters. 588. 216813–216813. 3 indexed citations
3.
Liu, Yue, Xiying Yu, & Wei Jiang. (2024). The Role of Mitochondrial Pyruvate Carrier in Neurological Disorders. Molecular Neurobiology. 62(3). 2846–2856. 2 indexed citations
4.
Mao, Linlin, Guodong Deng, Mengfan Li, et al.. (2024). Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells. European journal of medical research. 29(1). 293–293. 3 indexed citations
5.
Xu, Lei, Shichao Kan, Xiying Yu, et al.. (2023). Deep learning enables stochastic optical reconstruction microscopy-like superresolution image reconstruction from conventional microscopy. iScience. 26(11). 108145–108145. 6 indexed citations
6.
Yu, Xiaohong, Hui Yuan, Ya‐Nan Yang, et al.. (2023). Mammalian esophageal stratified tissue homeostasis is maintained distinctively by the epithelial pluripotent p63+Sox2+ and p63−Sox2+ cell populations. Cellular and Molecular Life Sciences. 80(10). 305–305. 2 indexed citations
7.
Yu, Shengji, et al.. (2022). Transcription-associated cyclin-dependent kinase 12 (CDK12) as a potential target for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(1). 188842–188842. 10 indexed citations
8.
Jiang, Xingran, Xiang Zhou, Xiying Yu, et al.. (2022). High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients. Modern Pathology. 35(7). 929–937. 18 indexed citations
9.
Yang, Yanan, Guodong Deng, Lili Qiao, et al.. (2022). Identification and characterization of stem cells in mammalian esophageal stratified squamous epithelia. Journal of Molecular Cell Biology. 14(6). 8 indexed citations
10.
Zou, Zhigeng, Wei Zheng, Guodong Deng, et al.. (2021). Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells. British Journal of Cancer. 125(6). 826–838. 11 indexed citations
11.
Zhang, Xinxin, Xiying Yu, Zhenguo Zhao, et al.. (2019). MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9. Bone. 130. 115139–115139. 26 indexed citations
12.
Hong, Ruoxi, Fei Ma, Weimin Zhang, et al.. (2016). 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells. BMC Cancer. 16(1). 725–725. 26 indexed citations
13.
Xue, Lei, Xiying Yu, Xingran Jiang, et al.. (2016). TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141. Oncotarget. 8(12). 19274–19284. 20 indexed citations
14.
Jiang, Xingran, Xiying Yu, Jin‐Hu Fan, et al.. (2014). RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death. Cancer Letters. 353(1). 78–86. 32 indexed citations
15.
Yu, Xiying, Xingran Jiang, Hongxia Li, et al.. (2013). miR-203 Inhibits the Proliferation and Self-Renewal of Esophageal Cancer Stem-Like Cells by Suppressing Stem Renewal Factor Bmi-1. Stem Cells and Development. 23(6). 576–585. 78 indexed citations
16.
Wang, Xiaobing, Xingran Jiang, Xiying Yu, et al.. (2013). Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody‐based therapy. Cancer Science. 105(2). 176–185. 38 indexed citations
17.
Yu, Xiying, et al.. (2013). DUSP6, a tumor suppressor, is involved in differentiation and apoptosis in esophageal squamous cell carcinoma. Oncology Letters. 6(6). 1624–1630. 21 indexed citations
18.
Zhao, Dan, Qiming Wang, Xiying Yu, et al.. (2012). MicroRNA‐1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma. Molecular Carcinogenesis. 52(8). 581–590. 42 indexed citations
19.
Sun, Guoqiang, et al.. (2010). Novel cancer suppressor gene for esophageal cancer: manganese superoxide dismutase. Diseases of the Esophagus. 24(5). 346–353. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mar Haz‐Conde Breakdown of academic impact, for papers by Young‐Kyoung Shin Breakdown of academic impact, for papers by Raquel Batlle Breakdown of academic impact, for papers by Jae Hwi Song Breakdown of academic impact, for papers by Naoki Hayashi Breakdown of academic impact, for papers by Francisco Hermida‐Prado Breakdown of academic impact, for papers by Katelyn N. Nelson Breakdown of academic impact, for papers by Chuang Lin Breakdown of academic impact, for papers by Yi‐Fang Yang
Rankless by CCL
2026